Marcus Westerberg
Forskningsassistent vid Institutionen för kirurgiska vetenskaper; Urologkirurgi
- E-post:
- marcus.westerberg@uu.se
- Besöksadress:
- Akademiska sjukhuset, ingång 70, 1 tr
751 85 UPPSALA - Postadress:
- Akademiska sjukhuset, ingång 70, 1 tr
751 85 UPPSALA
Mer information visas för dig som medarbetare om du loggar in.
Publikationer
Senaste publikationer
- Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer (2024)
- Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy (2023)
- Design considerations for observational studies of drugs for advanced cancer (2023)
- Endoscopist Characteristics and Polyp Detection in Colonoscopy (2023)
- Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden (2023)
Alla publikationer
Artiklar
- Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer (2024)
- Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy (2023)
- Design considerations for observational studies of drugs for advanced cancer (2023)
- Endoscopist Characteristics and Polyp Detection in Colonoscopy (2023)
- Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden (2023)
- Estimation in discrete time coarsened multivariate longitudinal models (2023)
- Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence. (2023)
- Watch out for sticky diagnosis bias in older men with prostate cancer (2022)
- Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists (2022)
- Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO) (2022)
- Mortality in men with castration‐resistant prostate cancer—A long‐term follow‐up of a population‐based real‐world cohort (2022)
- Changes in Characteristics of Men with Lethal Prostate Cancer During the Past 25 Years: Description of Population-based Deaths (2022)
- Detection rates of colorectal neoplasia during colonoscopies and their associated factors in the SCREESCO study (2022)
- Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy (2022)
- Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data (2022)
- Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy (2022)
- Variation in Prostate-Specific Antigen Testing Rates and Prostate Cancer Treatments and Outcomes in a National 20-Year Cohort (2021)
- Simulation model of disease incidence driven by diagnostic activity (2021)
- Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016 (2020)
- Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade (2020)
- Temporal changes in survival in men with de novo metastatic prostate cancer (2020)
- Nationwide study of time trends in prostate cancer death over two decades
- Different assumptions about missingness in registration of metastatic status have important implications for following trends in cancer presentation
Böcker
